Related references
Note: Only part of the references are listed.2010 TNM Staging System for Cutaneous MelanomaaEuro¦and Beyond
Jeffrey E. Gershenwald et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
A KRAS-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk
Elena Ratner et al.
CANCER RESEARCH (2010)
c-Kit mutants require hypoxia-inducible factor 1α to transform melanocytes
G. Monsel et al.
ONCOGENE (2010)
MicroRNA-dependent regulation of ckit in cutaneous melanoma
O. Igoucheva et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
A Risk Variant in an miR-125b Binding Site in BMPR1B Is Associated with Breast Cancer Pathogenesis
Pal Saetrom et al.
CANCER RESEARCH (2009)
Genetic Subgrouping of Melanoma Reveals New Opportunities for Targeted Therapy
Keiran S. M. Smalley et al.
CANCER RESEARCH (2009)
Genome-wide screen of promoter methylation identifies novel markers in melanoma
Yasuo Koga et al.
GENOME RESEARCH (2009)
Genetic risk factors for melanoma
Kathrine Damm Meyle et al.
HUMAN GENETICS (2009)
Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas
Atsuko Ashida et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Database resources of the National Center for Biotechnology Information
Eric W. Sayers et al.
NUCLEIC ACIDS RESEARCH (2009)
Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications
Ruth Halaban et al.
PLOS ONE (2009)
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine
Prasun J. Mishra et al.
PHARMACOGENOMICS (2009)
Global variation in CYP2C8-CYP2C9 functional haplotypes
William C. Speed et al.
PHARMACOGENOMICS JOURNAL (2009)
Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer
Krystian Jazdzewski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression
Keiran S. M. Smalley et al.
CANCER RESEARCH (2008)
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms
Federica Felicetti et al.
CANCER RESEARCH (2008)
A SNP in a let-7 microRNA Complementary Site in the KRAS 3′ Untranslated Region Increases Non-Small Cell Lung Cancer Risk
Lena J. Chin et al.
CANCER RESEARCH (2008)
Epstein-Barr virus-mediated dysregulation of human microRNA expression
Sirie E. Godshalk et al.
CELL CYCLE (2008)
Imatinib Targeting of KIT-Mutant Oncoprotein in Melanoma
Xiaofeng Jiang et al.
CLINICAL CANCER RESEARCH (2008)
Major response to imatinib mesylate in KIT-mutated melanoma
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation
Jose Lutzky et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
Roles of microRNAs and their targets in cancer
Giovanni Stefani
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Evolutionary conservation of microRNA regulatory circuits: An examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny
Chung-Tien Lee et al.
DNA AND CELL BIOLOGY (2007)
Somatic activation of KIT in distinct subtypes of melanoma
John A. Curtin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes
Vitali Alexeev et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
The role of microRNA genes in papillary thyroid carcinoma
HL He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Prevalence of KIT expression in human tumors
PT Went et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
dbSNP: the NCBI database of genetic variation
ST Sherry et al.
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
